About InVivo Biosystems
InVivo Biosystems is a company based in United States founded in 2019. InVivo Biosystems has raised $8.16 million across 9 funding rounds from investors including HHS, Rogue Venture Partners and Portland Seed Fund. InVivo Biosystems operates in a competitive market with competitors including Biocytogen, Applied StemCell, GenOway, Interius Biotherapeutics and TransCure bioServices, among others.
- Headquarter United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Invitro Bio Systems Private Limited
- Date of Incorporation 01 Jul, 2004
- Jurisdiction Hyderabad-27., Telangana, India
-
Annual Revenue
$2.69 M (USD)26.38as on Mar 31, 2022
-
Net Profit
$434.68 K (USD)86.15as on Mar 31, 2022
-
EBITDA
$711.17 K (USD)125.47as on Mar 31, 2022
-
Total Equity Funding
$8.16 M (USD)
in 9 rounds
-
Latest Funding Round
$296.42 K (USD), Grant
May 01, 2024
-
Investors
HHS
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of InVivo Biosystems
Unlock access to complete
Unlock access to complete
Funding Insights of InVivo Biosystems
InVivo Biosystems has successfully raised a total of $8.16M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $296.42 thousand completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in InVivo Biosystems
InVivo Biosystems has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Rogue Venture Partners and Portland Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
US-based startups are accelerated and funded via venture capital support.
|
Locked | Locked | Locked | |
|
Startup accelerator
|
Locked | Locked | Locked |
Investor details for InVivo Biosystems
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InVivo Biosystems
Investment portfolio details for InVivo Biosystems
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InVivo Biosystems
Detailed financials for InVivo Biosystems
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invivo Biosystems Comparisons
Peer comparison for InVivo Biosystems
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InVivo Biosystems
InVivo Biosystems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Applied StemCell, GenOway, Interius Biotherapeutics and TransCure bioServices, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| Locked | Locked | Locked |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating multiple diseases
|
|
| Locked | Locked | Locked |
Humanized mouse models are developed for preclinical immune drug studies.
|
|
| Locked | Locked | Locked |
Drug response assays are performed using murine in vivo models.
|
Detailed competitors of InVivo Biosystems
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invivo Biosystems
Complete news archive for InVivo Biosystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InVivo Biosystems
InVivo Biosystems was founded in 2019.
InVivo Biosystems is headquartered in United States.
InVivo Biosystems is a funded company, having raised a total of $8.16M across 9 funding rounds to date.
Annual revenue of InVivo Biosystems is $2.69M as on Mar 31, 2022.
InVivo Biosystems was founded in 2019 in the United States, focusing on the biotechnology sector. Animal models such as C. elegans and zebrafish are utilized for transgenic and genome editing services. Assay kits, reagents including PCR master mix, custom in-vivo testing, and toxicity testing are offered to support research operations. These services enable analytical evaluations in disease modeling and related applications.
InVivo Biosystems's top competitors include Biocytogen, Applied StemCell and GenOway.
InVivo Biosystems has 6 investors. Key investors include HHS, Rogue Venture Partners, Portland Seed Fund, ONAMI, and Launch Oregon.